Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000919574-25-004735·SUTRO BIOPHARMA, INC.
Schedule 13G ownership disclosure
SUTRO BIOPHARMA INC
Common Stock, $0.001 par value · CUSIP: 869367102
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Suvretta Capital Management, LLC
Shares: 6,488,324.00 · Class: 7.7%
- Averill Master Fund, Ltd.
Shares: 6,461,305.00 · Class: 7.7%
- Aaron Cowen
Shares: 6,488,324.00 · Class: 7.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-004735
- Form type
- SCHEDULE 13G/A
- Filer
- SUTRO BIOPHARMA, INC.
- CIK
- CIK 1382101
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership